Mrv0541 02231218532D 16 15 0 0 1 0 999 V2000 21.4432 -17.2748 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 22.1577 -16.8623 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 20.7287 -16.8623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 21.4432 -18.0998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 22.8721 -17.2748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 20.0142 -17.2748 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 20.7287 -16.0373 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 20.7287 -18.5123 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 23.5867 -16.8623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 22.8721 -18.0998 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 24.3011 -17.2748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 25.0156 -16.8623 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 25.7301 -17.2748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 25.0156 -16.0373 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 26.4446 -16.8623 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 25.7301 -18.0998 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 1 0 0 0 1 3 1 0 0 0 0 1 4 1 0 0 0 0 2 5 1 0 0 0 0 3 6 1 0 0 0 0 3 7 2 0 0 0 0 4 8 1 0 0 0 0 5 9 1 0 0 0 0 5 10 2 0 0 0 0 9 11 1 0 0 0 0 11 12 1 0 0 0 0 12 13 1 0 0 0 0 12 14 1 6 0 0 0 13 15 1 0 0 0 0 13 16 2 0 0 0 0 M END > DB03408 > drugbank > N[C@@H](CCC(=O)N[C@@H](CS)C(O)=O)C(O)=O > InChI=1S/C8H14N2O5S/c9-4(7(12)13)1-2-6(11)10-5(3-16)8(14)15/h4-5,16H,1-3,9H2,(H,10,11)(H,12,13)(H,14,15)/t4-,5-/m0/s1 > RITKHVBHSGLULN-WHFBIAKZSA-N > C8H14N2O5S > 250.272 > 250.062342258 > 6 > 30 > -1.006348321187313 > 23.361346952294173 > 1 > 5 > 0 > 0 > (2S)-2-amino-4-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}butanoic acid > -2.53 > -3.772310175782215 > -1.98 > 0 > -1 > 0 > -1 > 3.7783691650062323 > 1.9096914223488342 > 9.239048816239574 > 129.72 > 56.311400000000006 > 7 > 1 > 2.62e+00 g/l > biotin > 0 > DB03408 > EXPT00168 > experimental > gamma-Glutamylcysteine > 5-L-Glutamyl-L-cysteine; gamma-Glu-Cys; gamma-L-Glutamyl-L-cysteine; Glu(-Cys); L-gamma-glutamyl-L-cysteine; L-gamma-Glutamylcysteine; γGluCys $$$$